The treatment could relieve haemophilia B patients from factor IX replacement drugs
UniQure has enrolled the first patient in its registration trial of haemophilia B gene therapy candidate AMT-061 as it tries to keep ahead of a rival project from Spark Therapeutics/Pfizer.
The subject is the first out of around 50 subjects that will be recruited into the open-label HOPE-B trial of AMT-061, an a...
Some post-surgical wounds, including following abdominal surgeries and mastectomies, may require suction drainage to prevent post operative complications due to edema and fluid collections. Suction bulbs have been common for the past few decades, since they don’t require external power and are very simple in design. New technologies can significantly improve this, as batteries have become mo...
When Roche got Herceptin onto China’s national insurance program, it didn’t expect demand to surge so quickly, overwhelming its production capacity there. Now, to cope with a nationwide shortage, it’s shifting to a different manufacturing site to amp up supplies of the cancer therapy.
Roche applied to change Herceptin's existing production site for China to a high...
French biotech Abivax’s might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.
The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464.
The study aimed at acc...